How to Be Sure Your Team Understands Important Updates to your Clinical Trial

by Kelly Ritch May 27 , 2020 4 min read

Your protocol has been amended. There’s been a key finding that requires a change in procedure. Maybe there’s a new working practice document. Whatever the specifics, vital information has been dispersed to the team and all individuals have acknowledged that they have read it. But how confident are you that everyone who needs to understand the information really does? On what is your confidence based? 

For an industry devoted to scientific study and evidence-based medicine, we take a lot on faith. 

At ArcheMedX, we have found that almost no one currently assesses whether or not clinical trial staff truly understand important trial updates like protocol amendments and new SOPs. Many sponsors don’t measure staff competence or confidence. They don’t even verify whether or not important documents or key written communications are actually read 

Keeping Up With It All 

A number of things change over the course of the average clinical trial. Today, as we all struggle to find the path forward in the age of COVID-19, we can expect there to be a great deal more modification of procedures. For clinical trial teams, that means more to absorb, more to understand, and more to master. For sponsors, that means more risk.  

If you don’t want to live with this level of risk hanging over your clinical trial operations, you’ve got to move beyond simply asking people to check a box and affirm that they’ve read a documentYou must be able to assess their understanding. And, where understanding is lacking, you must be able to systematically address the problem and monitor improvement. 

New call-to-action


Procedures, Protocols, and People, too

Procedures and protocols aren’t the only things that will be changing in clinical trials. Job roles and responsibilities will change as well. Clinical Research Associates (CRAs) are now doing remote monitoring, and a lot more of their visits are via the telephone. Consider your statisticians. In the days ahead, they will need to do more in the area of managing and interpreting missing data due to the impact of the pandemic. Medical writers need to know how to quickly handle all the new information that will be coming their way following the FDA guidance to report on what happened in your trial because of COVID-19. 

New tasks like these require new skills. How will you know whether or not the personnel is ready to meet their new responsibilities? The answer is not a check-the-box activity. Instead, it’s an enriched learning experience that layers in behavioral data and aligns with the way that we know adults learn With such an approach, you will improve performance and increase confidence, knowledge, and mastery across your teamYou will also generate the data that will show you both where you need to do more and where you are ready to go. 

Modernizing your approach to educating and assessing your clinical trial staff will elevate every aspect of your staff’s performance, and go a long way toward reducing the risk of error, misstep, and even failure. 

Learn how ArcheMedX can help you make it happen through our advanced approach to training and assessing site staff.   

New call-to-action

Related Post

3 min Read 20 Jan, 2021

The Evolving Role of Sites in Virtual & Decentralized Trials: Interview with Mary Costello of Medable

Mary Costello talks with Kelly Ritch, EVP of Product and Clinical Research Solutions, about how…

3 min Read 14 Dec, 2020

Demystifying Decentralized Clinical Trials: Interview with R’Kes Starling of Reveles Clinical

R'Kes Starling joins Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, to…

18 min Read 10 Dec, 2020

To Succeed with Virtual or Hybrid Clinical Trials, Listen to Patients and Sites

We recently spoke about virtual and hybrid clinical trials with Amy O’Sullivan, Director of North…